Statistics
Publications
6
Citations
450
H-Index
6
Active since
2012
Affiliations
Michael D. Arensman is an author at University of California, Los Angeles specializing in oncology, medicine, and pancreatic cancer.
Publications per year
2012–2025
6
6
The CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth
Michael D. Arensman, Donatello Telesca, Anna R. Lay et al. · Molecular Cancer Therapeutics · 2014 · 118 citations · Full text
Medicine, Oncology, Pharmacology +17
HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma
Anne Kovochich, Michael D. Arensman, Anna R. Lay et al. · Cancer · 2012 · 65 citations · Full text
Medicine, Cancer Biology, Oncology +16
Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer
Michael D. Arensman, Phillip Nguyen, Kathleen M. Kershaw et al. · Molecular Cancer Research · 2015 · 51 citations · Full text
Medicine, Oncology, Pharmacology +14
Anti-tumor immunity influences cancer cell reliance upon ATG7
Michael D. Arensman, Xiaoran Yang, Wenyan Zhong et al. · OncoImmunology · 2020 · 27 citations · Full text
Life Sciences, Immunology, Oncology +16
1–5 of 6